Presentation Information
[IL4]Genomic Medicine Japan and its mission
Hidehiro Mizusawa1,2,3 (1. Genomic Medicine Japan, 2. National Center of Neurology and Psychiatry, 3. Institute of Science Tokyo)
Prof. Hidehiro Mizusawa is Director-General of Genomic Medicine Japan since 2026,President Special Adviser and President Emeritus of National Center of Neurology andPsychiatry (NCNP) since 2021, Professor Emeritus and Specially-appointed Professorof Institute of Science Tokyo (IST, former Tokyo Medical and Dental University) since2014. He graduated with MD in 1976 from Faculty of Medicine of Tokyo University, wherehe received PhD in 1983. He moved to Tsukuba University as Assistant Professor in1984 and became Associate Professor of Department of Neurology in 1988. He has beenProfessor and Chairperson of Department of Neurology and Neurological Sciences, GraduateSchool of Medical and Dental Sciences, IST (1996 – 2014), where he has been Directorof Center for Brain Integration Research, Director of School of Medicine, Vice Directorof the Medical Hospital and Associate Managing Trustee for Research of the University.He was Director General of NCNP Hospital since 2014 and President of NCNP since 2016.He has contributed particularly to researches on pathogeneses of ALS, Pure Akinesia/PSP,SCA, mitochondrial neuropathy, distal myopathy and Prion disease. He was PI of StrategicResearch Program for Brain Sciences, Field E (Life Long Brain Health, 2010-2015),MEXT. He has long been Chairpersons of Research Committees on Prion disease and relatedsubjects (2002 - 2020) and Prion Disease Surveillance Committee (2010-2026), MHWL.He has been PI of Initiative on Rare and Undiagnosed Disease, AMED since 2015. Heserved as President of Japanese Society of Neurology (2010 - 2014) and was Presidentof PRION 2016 in Tokyo, President of World Congress of Neurology 2017 in Kyoto andVice President of International Congress of Neuropathology 2018 in Tokyo.
Password required to view
Log in
or